PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
42.50
+2.02 (4.99%)
Oct 29, 2024, 4:00 PM EDT - Market closed
PTC Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 38.54, with a low estimate of 17 and a high estimate of 64. The average target predicts a decrease of -9.32% from the current stock price of 42.50.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for PTCT stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 6 | 6 | 6 | 5 | 5 | 4 |
| Sell | 2 | 2 | 2 | 2 | 1 | 1 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 15 | 15 | 15 | 15 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $45 | Hold | Maintains | $32 → $45 | +5.88% | Oct 11, 2024 |
| Baird | Baird | Buy Reiterates $44 | Buy | Reiterates | $44 | +3.53% | Oct 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $32 → $34 | Hold | Maintains | $32 → $34 | -20.00% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $64 | Buy | Reiterates | $64 | +50.59% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $64 | Buy | Reiterates | $64 | +50.59% | Sep 17, 2024 |
Financial Forecast
Revenue This Year
751.73M
from 937.82M
Decreased by -19.84%
Revenue Next Year
696.52M
from 751.73M
Decreased by -7.34%
EPS This Year
-5.17
from -8.37
EPS Next Year
-3.98
from -5.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 805.5M | 911.0M | 1.2B | ||
| Avg | 751.7M | 696.5M | 829.7M | ||
| Low | 689.2M | 519.4M | 430.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -14.1% | 21.2% | 79.2% | ||
| Avg | -19.8% | -7.3% | 19.1% | ||
| Low | -26.5% | -30.9% | -38.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.87 | -0.81 | 0.59 | ||
| Avg | -5.17 | -3.98 | -2.01 | ||
| Low | -6.66 | -6.52 | -5.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.